Compounds > methotrexate
Page last updated: 2024-08-25

methotrexate and Cutaneous T-Cell Lymphoma

methotrexate has been researched along with Cutaneous T-Cell Lymphoma in 47 studies

Research

Studies (47)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (14.89)18.2507
2000's11 (23.40)29.6817
2010's21 (44.68)24.3611
2020's8 (17.02)2.80

Authors

AuthorsStudies
Altınay, S; Kural, A; Özmen, A; Tural, D; Tutar, Y1
Arakawa, F; Fujii, K; Higashi, Y; Kanekura, T; Matsuoka, A; Ohshima, K; Yoshimitsu, M1
Alam, A; Chhabra, NK; Kaushal, D; Lahoria, U; Nahar, U; Singh, S1
Elsea, D; Lilley, C; Lisano, J; Liu, J; Savage, KJ; Yu, KS1
Kashabano, JJ; Lugina, EL; Matiku, SB; Mruma, RM; Rugengamazi, E1
Delaleu, J; Dereure, O; Laroche, L; Lévy, A; Maubec, E; Rodrigues, F; Szablewski, V1
Leach, M; McKay, P; Oun, H; Wilson, M1
Choi, J; Daniels, J; Geskin, L; Nihal, M; Rook, AH; Stonesifer, CJ; Wood, GS; Wu, J1
Magro, CM; Nguyen, GH; Ruan, J; Wang, JY1
Geskin, L; Malone, DC1
Fernandez-Peñas, P; Pavli, A; Wain, T; Wells, J1
Callen, JP; Maderal, AD; Malone, JC1
Kim, YH; Rahbar, Z; Salva, KA; Wood, GS1
Wood, GS; Wu, J3
Andersen, RM; Larsen, MS; Lauritzen, AF; Poulsen, TS; Skov, L1
Aviles, A; Fernandez-Diez, J; Nambo, MJ; Neri, N; Silva, L1
Gilreath, JA; Halwani, AS; McPherson, JP; Sedillo, C; Vrontikis, A1
El Euch, D; Halouani, S; Kchir, N; Mna, AB; Mokni, M; Souissi, A; Zahani, A; Zaraa, I1
Han, C; Hou, S; Liu, J; Liu, X; Wang, B; Zhang, Z1
Dimitriadis, G; Gkontopoulos, K; Karakitsos, P; Konsta, E; Kontsioti, F; Mpakou, V; Mpazani, E; Papadavid, E; Papageorgiou, S; Pappa, V; Rigopoulos, D; Spathis, A; Vasilatou, D; Vikentiou, M1
Hoeger, PH; Kienast, AK; Tsianakas, A1
Fleischer, AB; Kannangara, AP; Levitan, D1
Momtaz, P; Zippin, JH1
Huwait, H; Michel, RP; Shustik, C; Wang, B1
Chen, XH; Li, B; Li, Y; Li, Z; Lin, HL1
Bagot, M; Bouaziz, JD; Briki, H; Delfau-Larue, MH; Molinier-Frenkel, V; Ortonne, N1
Brocard, A; Dréno, B; Knol, AC; Peuvrel, L; Quéreux, G; Renaut, JJ1
Fujii, M; Honma, M; Iizuka, H; Ishida-Yamamoto, A; Ito, Y; Takahashi, H; Uehara, J1
Megahed, M; Rübben, A; Rütten, A; Weinstabl, A1
Balaraman, B; Conley, JA; Sheinbein, DM1
Tsai, HJ; Wu, WM1
Aragane, Y; Hashimoto, K; Isogai, R; Kanamaru, A; Kawada, A; Maeda, Y; Tezuka, T1
Galanski, M; Lotz, J; Opherk, JP1
Lane, JE; Parker, SR; Solomon, AR1
Christensen, HK; Thomsen, K; Vejlsgaard, GL1
Zackheim, HS3
Bia, FJ; Edelson, RL; Eisen, RN; Frieden, TR; Heald, PW; Patterson, TF1
Hwang, ST; Kashani-Sabet, M; Zackheim, HS1
Aplin, CG; Russell-Jones, R1
D'Incan, M; Déchelotte, P; Dubost, JJ; Franck, F; Soubrier, M; Souteyrand, P; Tournadre, A1
Jackson, R; McKenzie, KJ; Thomson, AB; Wallace, WH1
Alimena, G; Breccia, M; Carmosino, I; D'Andrea, M; D'Elia, GM; Petti, MC1
Gollnick, H; Martens-Lobenhoffer, J; Meyer, FP; Stötzel, B; Tröger, U1

Reviews

10 review(s) available for methotrexate and Cutaneous T-Cell Lymphoma

ArticleYear
Pralatrexate for Peripheral T-Cell Lymphoma (PTCL): Chance Only Supports The Prepared Mind.
    Anti-cancer agents in medicinal chemistry, 2023, Volume: 23, Issue:3

    Topics: COVID-19; Folic Acid Antagonists; Humans; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Meta-Analysis as Topic; Methotrexate; Neoplasm Recurrence, Local; SARS-CoV-2; Skin Neoplasms; Systematic Reviews as Topic; United States

2023
Primary Cutaneous Follicular Helper T-Cell Lymphoma: A Case Series and Review of the Literature.
    The American Journal of dermatopathology, 2017, Volume: 39, Issue:5

    Topics: Aged; Biopsy, Needle; Combined Modality Therapy; Dermatologic Surgical Procedures; Follow-Up Studies; Humans; Immunohistochemistry; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Middle Aged; Rare Diseases; Risk Assessment; Skin Neoplasms; T-Lymphocytes, Helper-Inducer; Treatment Outcome; Young Adult

2017
Methotrexate and Pralatrexate.
    Dermatologic clinics, 2015, Volume: 33, Issue:4

    Topics: Aminopterin; Antimetabolites, Antineoplastic; Apoptosis; DNA Methylation; Epigenesis, Genetic; Folic Acid Antagonists; Humans; Lymphoma, T-Cell, Cutaneous; Methotrexate; S Phase; Skin Neoplasms

2015
Infantile-onset cutaneous T-cell lymphoma.
    The British journal of dermatology, 2008, Volume: 159, Issue:6

    Topics: Adolescent; Antimetabolites, Antineoplastic; Child; Child, Preschool; Diagnosis, Differential; Humans; Infant; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Mycosis Fungoides; Skin Neoplasms; Treatment Outcome; Ultraviolet Therapy

2008
Cutaneous T-cell lymphoma: a review of current therapies and the future therapeutic implications of chemokine biology.
    Journal of drugs in dermatology : JDD, 2009, Volume: 8, Issue:12

    Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Chemokines; Humans; Lymphoma, T-Cell, Cutaneous; Mechlorethamine; Methotrexate; Photochemotherapy; Phototherapy; Retinoids; Signal Transduction; Skin Neoplasms

2009
Evaluation of cutaneous angioimmunoblastic T-cell lymphoma.
    Journal of the American Academy of Dermatology, 2011, Volume: 65, Issue:4

    Topics: Aged; Arthralgia; Cyclophosphamide; Deoxycytidine; Diphtheria Toxin; Doxorubicin; Epstein-Barr Virus Infections; Gemcitabine; Gene Rearrangement, T-Lymphocyte; Humans; Immunoblastic Lymphadenopathy; Interleukin-2; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Prednisolone; Pruritus; Recombinant Fusion Proteins; Retrospective Studies; Skin Neoplasms; Stem Cell Transplantation; Vinblastine; Vincristine; Vinorelbine

2011
Treatment of cutaneous T-cell lymphoma.
    Seminars in dermatology, 1994, Volume: 13, Issue:3

    Topics: Carmustine; Combined Modality Therapy; Humans; Interferon-alpha; Lymphoma, T-Cell, Cutaneous; Mechlorethamine; Methotrexate; Prognosis; PUVA Therapy; Skin Neoplasms

1994
Cutaneous T cell lymphoma: update of treatment.
    Dermatology (Basel, Switzerland), 1999, Volume: 199, Issue:2

    Topics: Administration, Topical; Adrenal Cortex Hormones; Antineoplastic Agents, Alkylating; Beta Particles; Carmustine; Humans; Interferon-alpha; Lymphoma, T-Cell, Cutaneous; Mechlorethamine; Methotrexate; PUVA Therapy; Retinoids; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays

1999
Cutaneous lymphoma associated with Epstein-Barr virus infection in 2 patients treated with methotrexate.
    Mayo Clinic proceedings, 2001, Volume: 76, Issue:8

    Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Burkitt Lymphoma; Dermatologic Agents; Dermatomyositis; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; In Situ Hybridization; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Middle Aged; RNA, Viral; Skin

2001
Subcutaneous panniculitic T-cell lymphoma in childhood: successful response to chemotherapy.
    Medical and pediatric oncology, 2001, Volume: 37, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Diagnosis, Differential; Doxorubicin; Head; Humans; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Neck; Panniculitis; Prednisolone; Radiography; Skin Neoplasms; Vincristine

2001

Trials

1 trial(s) available for methotrexate and Cutaneous T-Cell Lymphoma

ArticleYear
Interferon and low doses of methotrexate versus interferon and retinoids in the treatment of refractory/relapsed cutaneous T-cell lymphoma.
    Hematology (Amsterdam, Netherlands), 2015, Volume: 20, Issue:9

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Recombinant Proteins; Remission Induction; Skin Neoplasms; Survival Analysis; T-Lymphocytes; Treatment Outcome; Tretinoin

2015

Other Studies

36 other study(ies) available for methotrexate and Cutaneous T-Cell Lymphoma

ArticleYear
Subcutaneous panniculitis-like T-cell lymphoma associated with methotrexate treatment.
    The Journal of dermatology, 2022, Volume: 49, Issue:12

    Topics: Diagnosis, Differential; Humans; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Methotrexate; Panniculitis; Skin Neoplasms

2022
Relapsing subcutaneous panniculitis-like T-cell lymphoma with B symptoms, remitting on low dose methotrexate.
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2022, Volume: 20, Issue:10

    Topics: Humans; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Methotrexate; Neoplasm Recurrence, Local; Panniculitis; Skin Neoplasms

2022
Cost-Effectiveness of Brentuximab Vedotin Versus Physician's Choice of Methotrexate or Bexarotene for the Treatment of Cutaneous T-cell Lymphoma in Canada.
    Advances in therapy, 2023, Volume: 40, Issue:5

    Topics: Bexarotene; Brentuximab Vedotin; Canada; Cost-Benefit Analysis; Humans; Immunoconjugates; Lymphoma, T-Cell, Cutaneous; Methotrexate; Neoplasm Recurrence, Local; Physicians; Skin Neoplasms

2023
Mycosis fungoides with spongiosis: a case report.
    Journal of medical case reports, 2023, Nov-03, Volume: 17, Issue:1

    Topics: Adult; Edema; Humans; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Mycosis Fungoides; Skin Neoplasms

2023
Methotrexate-induced Primary Cutaneous Diffuse Large B-cell Lymphoma in Patients with Erythrodermic Cutaneous T-cell Lymphoma.
    Acta dermato-venereologica, 2020, Aug-17, Volume: 100, Issue:15

    Topics: Epstein-Barr Virus Infections; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Cutaneous; Methotrexate; Mycosis Fungoides; Skin Neoplasms

2020
Central nervous system relapse of primary cutaneous CD8
    British journal of haematology, 2021, Volume: 193, Issue:1

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Autografts; CD8-Positive T-Lymphocytes; Central Nervous System; Cranial Nerve Diseases; Cytarabine; Humans; Lymphoma, T-Cell, Cutaneous; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Recurrence; Referral and Consultation; Remission Induction; Skin Neoplasms; Spinal Puncture; Stem Cell Transplantation; T-Lymphocytes, Cytotoxic; Treatment Outcome

2021
Epigenetic Regulation of Apoptosis in Cutaneous T-Cell Lymphoma: Implications for Therapy with Methotrexate, Jak Inhibitors, and Resveratrol.
    The Journal of investigative dermatology, 2022, Volume: 142, Issue:2

    Topics: Acetylation; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase Inhibitors; Lymphoma, T-Cell, Cutaneous; Methotrexate; Protein Processing, Post-Translational; Resveratrol; Skin Neoplasms

2022
An exploratory cost-effectiveness analysis of systemic treatments for cutaneous T-cell lymphoma.
    The Journal of dermatological treatment, 2018, Volume: 29, Issue:5

    Topics: Antineoplastic Agents; Bexarotene; Cost-Benefit Analysis; Diphtheria Toxin; Humans; Hydroxamic Acids; Interferon-alpha; Interleukin-2; Lymphoma, T-Cell, Cutaneous; Methotrexate; Photopheresis; Recombinant Fusion Proteins; Skin Neoplasms; Tetrahydronaphthalenes; Treatment Outcome; Vorinostat

2018
The efficacy and safety of methotrexate versus interferon in cutaneous T-cell lymphomas.
    The Journal of dermatological treatment, 2018, Volume: 29, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Exanthema; Female; Humans; Interferons; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Middle Aged; Retrospective Studies; Skin; Treatment Outcome

2018
Methotrexate-Associated B-Cell Lymphoproliferative Disease in a Patient With Cutaneous T-Cell Lymphoma.
    JAMA dermatology, 2018, 04-01, Volume: 154, Issue:4

    Topics: Aged; Antimetabolites, Antineoplastic; B-Lymphocytes; Dermatitis; Facial Dermatoses; Humans; Lymphoma, T-Cell, Cutaneous; Lymphoproliferative Disorders; Male; Methotrexate; Scalp Dermatoses; Skin Neoplasms

2018
Epigenetically Enhanced PDT Induces Significantly Higher Levels of Multiple Extrinsic Pathway Apoptotic Factors than Standard PDT, Resulting in Greater Extrinsic and Overall Apoptosis of Cutaneous T-cell Lymphoma.
    Photochemistry and photobiology, 2018, Volume: 94, Issue:5

    Topics: Aminolevulinic Acid; Apoptosis; Epigenesis, Genetic; Humans; Immunohistochemistry; Ligands; Lymphoma, T-Cell, Cutaneous; Methotrexate; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms

2018
Analysis of the Effect of Gentian Violet on Apoptosis and Proliferation in Cutaneous T-Cell Lymphoma in an In Vitro Study.
    JAMA dermatology, 2018, 10-01, Volume: 154, Issue:10

    Topics: Anti-Infective Agents, Local; Antimetabolites, Antineoplastic; Apoptosis; Calcium; Caspase 8; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Fas Ligand Protein; Gentian Violet; Humans; In Vitro Techniques; Lymphoma, T-Cell, Cutaneous; Methotrexate; Myeloid Cell Leukemia Sequence 1 Protein; NF-kappa B; Phospholipase C gamma; Phosphorylation; Reactive Oxygen Species; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Skin Neoplasms; TNF-Related Apoptosis-Inducing Ligand

2018
Lymphomatoid papulosis type D or an aggressive epidermotropic CD8(+) cytotoxic T-cell lymphoma?
    Acta dermato-venereologica, 2014, Volume: 94, Issue:4

    Topics: Biopsy; Diagnosis, Differential; Drug Substitution; Female; Humans; Immunohistochemistry; Immunosuppressive Agents; Lymphoma, T-Cell, Cutaneous; Lymphomatoid Papulosis; Methotrexate; Middle Aged; Predictive Value of Tests; Skin; Skin Neoplasms; Steroids; T-Lymphocytes, Cytotoxic; Treatment Outcome

2014
Pralatrexate Monitoring Using a Commercially Available Methotrexate Assay to Avoid Potential Drug Interactions.
    Pharmacotherapy, 2016, Volume: 36, Issue:2

    Topics: Aged; Aminopterin; Drug Interactions; Drug Monitoring; Folic Acid Antagonists; Furosemide; Humans; Infusions, Intravenous; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Pleural Effusion; Reagent Kits, Diagnostic; Skin Neoplasms; Sodium Potassium Chloride Symporter Inhibitors; Treatment Outcome

2016
Methotrexate-induced necrolysis in tumoral-stage mycosis fungoides: a challenging diagnosis.
    Dermatology online journal, 2016, Jan-15, Volume: 22, Issue:1

    Topics: Humans; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Middle Aged; Mycosis Fungoides; Neoplasm Staging; Skin; Skin Neoplasms

2016
A case of primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoma.
    European journal of dermatology : EJD, 2016, Dec-01, Volume: 26, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; Eyelid Neoplasms; Humans; Interferon-alpha; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Skin Neoplasms

2016
Apoptosis Induction and Gene Expression Profile Alterations of Cutaneous T-Cell Lymphoma Cells following Their Exposure to Bortezomib and Methotrexate.
    PloS one, 2017, Volume: 12, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Bortezomib; Cell Line, Tumor; DNA Repair; Flow Cytometry; Gene Expression Profiling; Humans; Lymphoma, T-Cell, Cutaneous; Methotrexate; Polymerase Chain Reaction; Signal Transduction

2017
Evaluation of the efficacy of the combination of oral bexarotene and methotrexate for the treatment of early stage treatment-refractory cutaneous T-cell lymphoma.
    The Journal of dermatological treatment, 2009, Volume: 20, Issue:3

    Topics: Administration, Oral; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Middle Aged; Mycosis Fungoides; Neoplasm Staging; Retrospective Studies; Risk Assessment; Sex Factors; Skin Neoplasms; Survival Rate; Tetrahydronaphthalenes; Treatment Outcome

2009
Composite cutaneous lymphoma in a patient with rheumatoid arthritis treated with methotrexate.
    The American Journal of dermatopathology, 2010, Volume: 32, Issue:1

    Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; DNA, Neoplasm; Female; Gene Rearrangement, B-Lymphocyte; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Gene Rearrangement, T-Lymphocyte; Humans; Lymphoma, B-Cell; Lymphoma, T-Cell, Cutaneous; Methotrexate; Neoplasms, Multiple Primary; Skin Neoplasms

2010
Primary cutaneous blastic plasmacytoid dendritic cell neoplasm without extracutaneous manifestation: case report and review of the literature.
    Pathology, research and practice, 2011, Jan-15, Volume: 207, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; CD4 Antigens; CD56 Antigen; Cyclophosphamide; Dendritic Cells; Dexamethasone; Diagnosis, Differential; Doxorubicin; Humans; Immunohistochemistry; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Middle Aged; Remission Induction; Skin; Skin Neoplasms; Treatment Outcome; Vincristine

2011
Subcutaneous panniculitis-like T-cell lymphoma αβ: complete sustained remission with corticosteroids and methotrexate.
    The British journal of dermatology, 2010, Volume: 163, Issue:5

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Antigens, CD; Antimetabolites, Antineoplastic; Female; Humans; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Panniculitis; Skin Neoplasms; T-Lymphocytes; Treatment Outcome; Young Adult

2010
Sudden onset of an aggressive cutaneous lymphoma in a young patient with psoriasis: role of immunosuppressants.
    Acta dermato-venereologica, 2010, Volume: 90, Issue:6

    Topics: Adult; Antibiotics, Antineoplastic; Biopsy; Cyclosporine; Doxorubicin; Etanercept; Fatal Outcome; Humans; Immunoglobulin G; Immunosuppressive Agents; Leg; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Neoplasm Invasiveness; Neoplasm Staging; Polyethylene Glycols; Psoriasis; Receptors, Tumor Necrosis Factor; Skin Neoplasms; Treatment Failure

2010
Reduction of Fas/CD95 promoter methylation, upregulation of Fas protein, and enhancement of sensitivity to apoptosis in cutaneous T-cell lymphoma.
    Archives of dermatology, 2011, Volume: 147, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Azacitidine; Cell Line, Tumor; DNA Methylation; Drug Resistance, Neoplasm; fas Receptor; Female; Humans; Interferon Type I; Interferon-alpha; Lymphoma, T-Cell, Cutaneous; Methotrexate; NF-kappa B; Promoter Regions, Genetic; Recombinant Proteins; Skin Neoplasms; Up-Regulation

2011
Primary cutaneous γδ-T-cell lymphoma treated with low-dose methotrexate and narrowband ultraviolet B irradiation: report of a case with testicular involvement.
    The Journal of dermatology, 2011, Volume: 38, Issue:4

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Humans; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Receptors, Antigen, T-Cell, gamma-delta; Skin Neoplasms; Testicular Neoplasms; Ultraviolet Therapy

2011
[Cutaneous cytotoxic T-cell lymphoma].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2011, Volume: 62, Issue:5

    Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Female; Humans; Lymphoma, T-Cell, Cutaneous; Methotrexate; Skin Neoplasms; Treatment Outcome

2011
Lymphomatoid papulosis histopathologically simulating angiocentric and cytotoxic T-cell lymphoma: a case report.
    The American Journal of dermatopathology, 2004, Volume: 26, Issue:2

    Topics: Adult; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Cell Nucleus; Clone Cells; Diagnosis, Differential; DNA, Neoplasm; Female; Humans; Immunophenotyping; Lymphoma, T-Cell, Cutaneous; Lymphomatoid Papulosis; Methotrexate; T-Lymphocytes, Cytotoxic; Treatment Outcome

2004
Nasal-type NK/T-cell lymphoma successfully treated with ProMACE-CytaBOM therapy.
    Dermatology (Basel, Switzerland), 2004, Volume: 209, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Facial Neoplasms; Humans; Killer Cells, Natural; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Prednisone; Skin Neoplasms; Vincristine

2004
[Cardiac infiltration as complication of cutaneous T-lymphoblastic non-Hodgkin's lymphoma].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2007, Volume: 179, Issue:2

    Topics: Antimetabolites, Antineoplastic; Combined Modality Therapy; Heart Atria; Heart Neoplasms; Heart Ventricles; Humans; Injections, Spinal; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Radiography, Thoracic; Skin Neoplasms; Time Factors; Tomography, X-Ray Computed; Tricuspid Valve

2007
A report of Epstein-Barr virus-positive primary cutaneous natural killer-/T-cell lymphoma.
    Journal of the American Academy of Dermatology, 2008, Volume: 59, Issue:1

    Topics: Administration, Oral; Arthritis, Rheumatoid; Biopsy; Epstein-Barr Virus Infections; Female; Humans; Killer Cells, Natural; Lymphocyte Subsets; Lymphoma, T-Cell, Cutaneous; Methotrexate; Middle Aged; Skin

2008
Lymphomatoid papulosis: a follow-up study of 41 patients.
    Seminars in dermatology, 1994, Volume: 13, Issue:3

    Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Cutaneous; Lymphomatoid Papulosis; Male; Methotrexate; Middle Aged; PUVA Therapy

1994
Cutaneous cryptococcosis in a patient with cutaneous T cell lymphoma receiving therapy with photopheresis and methotrexate.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 17, Issue:4

    Topics: Aged; Amphotericin B; Chemotherapy, Adjuvant; Cryptococcosis; Dermatomycoses; Humans; Immunocompromised Host; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Photopheresis

1993
Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: results in twenty-nine patients.
    Journal of the American Academy of Dermatology, 1996, Volume: 34, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Dermatitis, Exfoliative; Disease-Free Survival; Female; Follow-Up Studies; Humans; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Middle Aged; Neoplasm Staging; Pruritus; Remission Induction; Retrospective Studies; Skin Neoplasms; Survival Rate; Treatment Outcome

1996
Acute dysarthria induced by low dose methotrexate therapy in a patient with erythrodermic cutaneous T-cell lymphoma: an unusual manifestation of neurotoxicity.
    Clinical and experimental dermatology, 1999, Volume: 24, Issue:1

    Topics: Acute Disease; Aged; Antimetabolites, Antineoplastic; Dysarthria; Humans; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Skin Neoplasms

1999
Cutaneous pleomorphic T-cell lymphoma coexisting with myelodysplastic syndrome transforming into acute myeloid leukemia: successful treatment with a fludarabine-containing regimen.
    European journal of haematology, 2002, Volume: 68, Issue:1

    Topics: Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Contraindications; Cytarabine; Disease Progression; Granulocyte Colony-Stimulating Factor; Humans; Immunophenotyping; Leukemia, Myeloid, Acute; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Neoplasms, Second Primary; Remission Induction; Skin Neoplasms; Vidarabine

2002
Drug points: Severe myalgia from an interaction between treatments with pantoprazole and methotrexate.
    BMJ (Clinical research ed.), 2002, Jun-22, Volume: 324, Issue:7352

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Barrett Esophagus; Benzimidazoles; Dermatologic Agents; Drug Interactions; Humans; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Middle Aged; Muscular Diseases; Omeprazole; Pain; Pantoprazole; Sulfoxides

2002
Subcutaneous administration of methotrexate.
    Journal of the American Academy of Dermatology, 1992, Volume: 26, Issue:6

    Topics: Costs and Cost Analysis; Humans; Injections, Subcutaneous; Lymphoma, T-Cell, Cutaneous; Methotrexate; Psoriasis

1992